Vestal Point Capital »

Palisade Bio shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 2.5M 1.75

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Palisade Bio

Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Ameriprise Financial
Commodore Capital
RA Capital Management
Franklin Resources
Eversept Partners
Goldman Sachs Group
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Dr. Jeffrey R. Jay, M.D.
Balyasny Asset Management
Federated Investors

View all funds holding Palisade Bio